Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biodexa Pharmaceuticals Announces Pricing Of $5M Registered Direct Offering To Sell An Aggregate Of 5,050,808 ADSs, And 278,975 Pre-Funded Warrants Exercisable For Depositary Shares, At A Purchase Price Of $0.94 Per Depositary Share; Also Announces Concurrent Private Placement

Author: Benzinga Newsdesk | July 19, 2024 08:32am

To Sell 5,050,808 American Depositary Shares And 278,975 Pre-Funded Warrants; Proceeds To Fund Development Programs Including $17M CPRIT Grant Match And Phase 3 eRapa Trial In Familial Adenomatous Polyposis, Working Capital, And General Corporate Purposes

Posted In: BDRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist